New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis

BackgroundThis study aimed to investigate whether triglyceride glucose-body mass index (TyG-BMI) and a new index using TyG-BMI (NITGB) could predict all-cause mortality in non-obese patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).MethodsThe medical records of 78...

Full description

Bibliographic Details
Main Authors: Pil Gyu Park, Jung Yoon Pyo, Sung Soo Ahn, Jason Jungsik Song, Yong-Beom Park, Ji Hye Huh, Sang-Won Lee
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1168016/full
_version_ 1797823673848037376
author Pil Gyu Park
Jung Yoon Pyo
Sung Soo Ahn
Jason Jungsik Song
Jason Jungsik Song
Yong-Beom Park
Yong-Beom Park
Ji Hye Huh
Sang-Won Lee
Sang-Won Lee
author_facet Pil Gyu Park
Jung Yoon Pyo
Sung Soo Ahn
Jason Jungsik Song
Jason Jungsik Song
Yong-Beom Park
Yong-Beom Park
Ji Hye Huh
Sang-Won Lee
Sang-Won Lee
author_sort Pil Gyu Park
collection DOAJ
description BackgroundThis study aimed to investigate whether triglyceride glucose-body mass index (TyG-BMI) and a new index using TyG-BMI (NITGB) could predict all-cause mortality in non-obese patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).MethodsThe medical records of 78 non-obese AAV patients (BMI < 23.0 kg/m2 for Asians) were retrospectively reviewed. TyG-BMI was calculated by the equation: Ln (triglyceride × fasting glucose/2) × BMI. To develop NITGB, we assigned a weight of a number close to an 0.1 decimal integer to each variable according to the slopes for independent variables with P-value < 0.1 in the multivariable Cox analysis.ResultsThe median age was 54.3 years and five patients died. When non-obese AAV patients were divided into two groups based on TyG-BMI ≥ 187.74, those with TyG-BMI ≥ 187.74 exhibited a significantly higher risk for all-cause mortality than those without (RR 9.450). Since age (HR 1.324), Birmingham vasculitis activity score (BVAS; HR 1.212), and TyG-BMI ≥ 187.74 (HR 12.168) were independently associated with all-cause mortality, NITGB was developed as follows: age + 0.2 × BVAS + 2.5 × TyG-BMI ≥ 187.74. When non-obese AAV patients were divided into two groups based on NITGB ≥ 27.36, those with NITGB ≥ 27.36 showed a significantly higher risk for all-cause mortality than those without (RR 284.000). Both non-obese AAV patients with TyG-BMI ≥ 187.74 and those with NITGB ≥ 27.36 exhibited significantly higher cumulative rates of all-cause mortality than those without.ConclusionNITGB along with TyG-BMI could predict all-cause mortality in non-obese AAV patients.
first_indexed 2024-03-13T10:27:27Z
format Article
id doaj.art-fb1396d25cf14db9b59e130b8f370b2d
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-13T10:27:27Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-fb1396d25cf14db9b59e130b8f370b2d2023-05-19T05:57:36ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-05-011010.3389/fmed.2023.11680161168016New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitisPil Gyu Park0Jung Yoon Pyo1Sung Soo Ahn2Jason Jungsik Song3Jason Jungsik Song4Yong-Beom Park5Yong-Beom Park6Ji Hye Huh7Sang-Won Lee8Sang-Won Lee9Division of Rheumatology, Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaInstitute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaInstitute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of KoreaDivision of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of KoreaInstitute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of KoreaBackgroundThis study aimed to investigate whether triglyceride glucose-body mass index (TyG-BMI) and a new index using TyG-BMI (NITGB) could predict all-cause mortality in non-obese patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).MethodsThe medical records of 78 non-obese AAV patients (BMI < 23.0 kg/m2 for Asians) were retrospectively reviewed. TyG-BMI was calculated by the equation: Ln (triglyceride × fasting glucose/2) × BMI. To develop NITGB, we assigned a weight of a number close to an 0.1 decimal integer to each variable according to the slopes for independent variables with P-value < 0.1 in the multivariable Cox analysis.ResultsThe median age was 54.3 years and five patients died. When non-obese AAV patients were divided into two groups based on TyG-BMI ≥ 187.74, those with TyG-BMI ≥ 187.74 exhibited a significantly higher risk for all-cause mortality than those without (RR 9.450). Since age (HR 1.324), Birmingham vasculitis activity score (BVAS; HR 1.212), and TyG-BMI ≥ 187.74 (HR 12.168) were independently associated with all-cause mortality, NITGB was developed as follows: age + 0.2 × BVAS + 2.5 × TyG-BMI ≥ 187.74. When non-obese AAV patients were divided into two groups based on NITGB ≥ 27.36, those with NITGB ≥ 27.36 showed a significantly higher risk for all-cause mortality than those without (RR 284.000). Both non-obese AAV patients with TyG-BMI ≥ 187.74 and those with NITGB ≥ 27.36 exhibited significantly higher cumulative rates of all-cause mortality than those without.ConclusionNITGB along with TyG-BMI could predict all-cause mortality in non-obese AAV patients.https://www.frontiersin.org/articles/10.3389/fmed.2023.1168016/fullantineutrophil cytoplasmic antibody-associated vasculitismortalitypredictindexTyG-BMI
spellingShingle Pil Gyu Park
Jung Yoon Pyo
Sung Soo Ahn
Jason Jungsik Song
Jason Jungsik Song
Yong-Beom Park
Yong-Beom Park
Ji Hye Huh
Sang-Won Lee
Sang-Won Lee
New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Frontiers in Medicine
antineutrophil cytoplasmic antibody-associated vasculitis
mortality
predict
index
TyG-BMI
title New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
title_full New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
title_fullStr New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
title_full_unstemmed New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
title_short New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
title_sort new index using triglyceride glucose body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody associated vasculitis
topic antineutrophil cytoplasmic antibody-associated vasculitis
mortality
predict
index
TyG-BMI
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1168016/full
work_keys_str_mv AT pilgyupark newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT jungyoonpyo newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT sungsooahn newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT jasonjungsiksong newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT jasonjungsiksong newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT yongbeompark newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT yongbeompark newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT jihyehuh newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT sangwonlee newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis
AT sangwonlee newindexusingtriglycerideglucosebodymassindexforpredictingmortalityinpatientswithantineutrophilcytoplasmicantibodyassociatedvasculitis